Literature DB >> 9705601

Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines?

F J Zijlstra1.   

Abstract

Smoking has either a beneficial or harmful effect on the course and recurrence of ulcerative colitis and Crohn's disease respectively. Transdermal application of nicotine had similar effects in ulcerative colitis and therefore was considered to be an effective basic drug which could be further developed in the search for new compounds in the treatment of acute exacerbations of corticosteroid resistant ulcerative colitis. In this communication the short-term use of nicotine in ulcerative colitis is reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705601      PMCID: PMC1781849          DOI: 10.1080/09629359891072

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  20 in total

1.  Effect of ulcerative colitis and smoking on rectal blood flow.

Authors:  E D Srivastava; M A Russell; C Feyerabend; J Rhodes
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Cholinergic muscarinic and nicotinic binding by human lymphocytes: differences between peripheral blood cells and cultivated cell lines.

Authors:  E Grabczewska; H Laskowska-Bozek; W Maśliński; J Ryzewski
Journal:  Int J Tissue React       Date:  1990

3.  Relation between nicotine intake and Alzheimer's disease.

Authors:  C M van Duijn; A Hofman
Journal:  BMJ       Date:  1991-06-22

4.  Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers.

Authors:  F J Zijlstra; J E Vincent; W M Mol; H C Hoogsteden; P T Van Hal; R C Jongejan
Journal:  Eur J Clin Invest       Date:  1992-05       Impact factor: 4.686

5.  A meta-analysis of the role of smoking in inflammatory bowel disease.

Authors:  B M Calkins
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

6.  Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking.

Authors:  P Hersey; D Prendergast; A Edwards
Journal:  Med J Aust       Date:  1983-10-29       Impact factor: 7.738

7.  Transdermal nicotine for active ulcerative colitis.

Authors:  R D Pullan; J Rhodes; S Ganesh; V Mani; J S Morris; G T Williams; R G Newcombe; M A Russell; C Feyerabend; G A Thomas
Journal:  N Engl J Med       Date:  1994-03-24       Impact factor: 91.245

8.  In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells.

Authors:  S Madretsma; L M Wolters; J P van Dijk; C J Tak; C Feyerabend; J H Wilson; F J Zijlstra
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-10       Impact factor: 2.566

9.  Effect of nicotine on rectal mucus and mucosal eicosanoids.

Authors:  F J Zijlstra; E D Srivastava; M Rhodes; A P van Dijk; F Fogg; H J Samson; M Copeman; M A Russell; C Feyerabend; G T Williams
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Smoking and intestinal absorption of oral polyethylene glycols in Crohn's disease.

Authors:  J Söderholm; G Olaison; R Sjödahl; C Tagesson
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

View more
  4 in total

1.  Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.

Authors:  S A Mitchell; M Thyssen; T R Orchard; D P Jewell; K A Fleming; R W Chapman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Inflammatory bowel disease, such as Ulcerative colitis, is a risk factor for recurrent thromboembolic events: a case report.

Authors:  Mortimer B O'Connor; Neil O'Donovan; Mark J Phelan; Michael J Regan
Journal:  Cases J       Date:  2009-10-29

Review 3.  Anti-inflammatory actions of acupuncture.

Authors:  Freek J Zijlstra; Ineke van den Berg-de Lange; Frank J P M Huygen; Jan Klein
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

4.  A Randomized Single Blind Parallel Group Study Comparing Monoherbal Formulation Containing Holarrhena Antidysenterica Extract with Mesalamine in Chronic Ulcerative Colitis Patients.

Authors:  Sarika Johari; Tejal Gandhi
Journal:  Anc Sci Life       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.